Our Patent Litigation team is a proud partner to the world’s most innovative life sciences and technology companies. Our experience successfully handling high-stakes patent matters, joined with Paul, Weiss's legendary litigation capabilities, enable us to provide comprehensive strategies to protect our clients’ most valuable innovations that extend well beyond traditional patent litigation.
Intellectual Property Litigation: Single Actor Not Required for Induced Infringement
October 16, 2012 Read the article
Litigation partner Lewis R. Clayton's Intellectual Property Litigation column appeared in the October 8 issue of the New York Law Journal. The article examines the en banc decision of the Federal Circuit Court of Appeals in Akamai Technologies Inc v. Limelight Networks Inc, in which a deeply split court considered significant issues concerning liability for induced infringement of method patents. Litigation associate Rachale C. Miller assisted in the preparation of this article.